Antiverse
Develops therapeutic antibodies for challenging disease targets using AI-driven techbio
$9.3MSeries A
Role not disclosedSV
Soulmates Ventures
Activity from announced rounds
Activity in this selectionthe-family-fund-075bdd15
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $10.7M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionFluoSphera
Develops human-based preclinical platform for drug safety and efficacy testing
€1.2MUndisclosed
Role not disclosed